BIOSCRIPT LIMITED

Active Macclesfield

Activities of other holding companies n.e.c.

13 employees website.com
Life sciences and medical technology Activities of other holding companies n.e.c.
B

BIOSCRIPT LIMITED

Activities of other holding companies n.e.c.

Founded 22 Feb 2021 Active Macclesfield, England 13 employees website.com
Life sciences and medical technology Activities of other holding companies n.e.c.

Previous Company Names

LIBRETTO BIDCO LIMITED 22 Feb 2021 — 29 Oct 2021
Accounts Submitted 27 Jun 2025 Next due 30 Jun 2026 2 months remaining
Confirmation Submitted 5 Feb 2026 Next due 6 Feb 2027 9 months remaining
Net assets £-26M £8M 2024 year on year
Total assets £66M £5M 2024 year on year
Total Liabilities £92M £14M 2024 year on year
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

Suite A, Greenway House Larkwood Way Tytherington Business Park Macclesfield SK10 2XR England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for BIOSCRIPT LIMITED (13216692), an active life sciences and medical technology company based in Macclesfield, England. Incorporated 22 Feb 2021. Activities of other holding companies n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2021–2024)

Cash in Bank

£41.09k

Increased by £37.51k (+1049%)

Net Assets

-£26.33M

Decreased by £8.38M (-47%)

Total Liabilities

£91.92M

Increased by £13.78M (+18%)

Turnover

£1.14M

Decreased by £132.59k (-10%)

Employees

13

Increased by 2 (+18%)

Debt Ratio

140%

Increased by 10 (+8%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

4 Allotments 120,095,621 Shares £4.02m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
26 Apr 202490,000,000£900k£0.01
29 Sept 202229,999,420£300k£0.01
30 Jul 20211£23k£23k
2 Mar 202196,200£2.80m£29.114

Officers

Officers

1 active 2 resigned
Status
James MaxwellDirectorBritishUnited Kingdom4115 Feb 2024Active

Shareholders

Shareholders (1)

Bioscript Midco 2 Limited
100.0%
522,342,829

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 22 Feb 2021
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

BB SHELF 4 LLP united kingdom
BIOSCRIPT LIMITED Current Company

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
5 Feb 2026Confirmation StatementConfirmation statement made on 2026-01-23 with no updates
27 Jun 2025AccountsAnnual accounts made up to 2024-09-30
7 Feb 2025OfficersChange to director Mr James Maxwell on 2025-02-06
6 Feb 2025Confirmation StatementConfirmation statement made on 2025-01-23 with updates
1 Oct 2024OfficersChange to director Mr James Maxwell on 2024-09-24
5 Feb 2026 Confirmation Statement

Confirmation statement made on 2026-01-23 with no updates

27 Jun 2025 Accounts

Annual accounts made up to 2024-09-30

7 Feb 2025 Officers

Change to director Mr James Maxwell on 2025-02-06

6 Feb 2025 Confirmation Statement

Confirmation statement made on 2025-01-23 with updates

1 Oct 2024 Officers

Change to director Mr James Maxwell on 2024-09-24

Recent Activity

Latest Activity

Confirmation statement made on 2026-01-23 with no updates

2 months ago on 5 Feb 2026

Annual accounts made up to 2024-09-30

10 months ago on 27 Jun 2025

Change to director Mr James Maxwell on 2025-02-06

1 years ago on 7 Feb 2025

Confirmation statement made on 2025-01-23 with updates

1 years ago on 6 Feb 2025

Change to director Mr James Maxwell on 2024-09-24

1 years ago on 1 Oct 2024